Abstract:

India's adaptogen market is expanding through the simultaneous influence of preventive-health demand, digital retail, traditional medicine, and premium nutraceutical consumption. This article examines how Panax ginseng is positioned within that environment and uses Bengaluru as an urban case through which its competitive relationship with ashwagandha can be interpreted. A qualitative secondary-research design was applied to regulatory documents, market reports, published clinical literature, and product information available through business-to-business and consumer-facing retail channels. The analysis indicates that the two botanicals enter the Indian market from unequal institutional positions. Ashwagandha benefits from domestic cultivation, longstanding Ayurvedic legitimacy, broad product diversity, and access to both traditional-medicine and food-based regulatory pathways. Panax ginseng is generally imported, placed within nutraceutical or health-supplement categories, and promoted through narrower claims relating to energy, stamina, cognition, and performance. Reported estimates place the Indian ashwagandha supplement market at USD 62.6 million in 2024, with projected growth of approximately 10.1% annually through 2033. By comparison, Panax ginseng draws commercial credibility mainly from a global market estimated at USD 2.47 billion in 2024 and projected to reach USD 4.68 billion by 2033. Evidence from five Bengaluru locations suggests that ashwagandha has much wider pharmacy and Ayurveda-store visibility, whereas Panax ginseng is encountered chiefly in premium, imported, or multi-ingredient formulations. The findings therefore support a relationship of partial overlap but stronger complementarity: ashwagandha serves the mass stress-management and general-wellness market, while Panax ginseng occupies a selective performance-oriented niche. Future growth for Panax ginseng is likely to depend on compliant consumer education, standardized extracts, transparent sourcing, direct-to-consumer distribution, and carefully designed combination products rather than direct price competition with ashwagandha.

Keywords:

Panax Ginseng, Indian Ginseng, FSSAI guidelines, CAGR, Ashwagandha, Ayurveda Aahara, ETC.

Aim/Objectives

Methods